Please login to the form below

Not currently logged in
Email:
Password:

Beijing Med-Pharm IPO raises USD 31m

Beijing Med-Pharm (BMP), a US headquartered pharmaceutical marketing and distribution company, has said it expects to receive USD 30.6m in proceeds from a direct offering of 3.5 million units.

Beijing Med-Pharm (BMP), a US headquartered pharmaceutical marketing and distribution company, has said it expects to receive USD 30.6m in proceeds from a direct offering of 3.5 million units.

The company said it has agreed to sell the units to institutional and individual investors for about USD 9.40 per share for a total consideration of approximately USD 32.6m minus expenses.

Each unit consists of one share of the company's common stock and warrants to purchase two-tenths of a share at an exercise price of USD 9.37 per share.

The closing of the offering is expected on or around 22 August.

Philadelphia Brokerage was the placement agent for the offering and will receive 60,896 shares of common stock as partial payment of its fee.

The company said it plans to use the proceeds to advance its operations and strategic plan, which includes the acquisition of a 49 per cent minority stake in over-the-counter manufacturer Sunstone Pharmaceutical. BMP also plans to expand the distribution of its products in China.

Sunstone is a privately held manufacturer of OTC medicines, with operations in Hebei Province, China. Because Sunstone is privately owned and the transaction will take place in Hong Kong, Chinese government approval is not required. The transaction is expected to close in Q3 FY07.

In early August 2007, BMP announced that the Ministry of Commerce (MOFCOM) of the People's Republic of China approved Alliance BMP's acquisition of a 50 per cent stake in Guangzhou Pharmaceuticals, the third largest pharmaceutical wholesaler in China. Alliance BMP is a UK-based investment vehicle 80 per cent-owned by Alliance Boots and 20 per cent-owned by BMP.

22nd August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics